Combined Dendritic Cell and Anti-TIGIT Immunotherapy Potentiates Adaptive NK Cells against HIV-1.

Investigators demonstrated that dendritic cells primed with nanoparticles containing Poly I:C enhanced the natural cytotoxic function of natural killer cells from effective responder people with HIV-1.